Biotech

All Articles

Lykos are going to inquire FDA to reexamine its choice following being rejected of MDMA treatment for post-traumatic stress disorder

.Observing an unsatisfactory revealing for Lykos Rehabs' MDMA applicant for post-traumatic stress di...

AN 2 fifty percents headcount, ceases phase 3 test after records disappoint

.AN2 Therapeutics is reassessing its company in feedback to poor midphase information, promising to ...

Merck pays for $700M for bispecific, snooping autoimmune position and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying out $700 thousand upfront to challenge Amgen in a blood stream cancer cell...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences on the verge of an FDA choice for its own liver health condition drug se...

' All hands on deck' at Lilly as peers target obesity market

.CEO David Ricks can easily see the providers putting together camping tents at basecamp responsible...

Entero giving up personnel, leaving office and also stopping briefly R&ampD

.Mattress Liquidators has actually transformed Entero Therapies white colored as a piece. The collec...

Exelixis falls ADC after deciding it is actually no suit for Tivdak

.Exelixis is quiting on its tissue factor (TF)- targeting antibody-drug conjugate after ending the a...

Relay dislikes SHP2 prevention after Genentech leaves behind

.Three full weeks after Roche's Genentech unit walked away from an SHP2 prevention deal, Relay Rehab...

Stoke's Dravet syndrome med discharged of partial clinical hold

.Stoke Rehabs' Dravet syndrome medication has been without a predisposed grip, removing the techniqu...

Fierce Biotech's Gabrielle Masson provides Fierce 15 at NYSE

.Fierce Biotech Associate Editor Gabrielle Masson offered the 2024 course of Ferocious 15 champions ...